Home › Overweight › Mississippi › Jackson
Overweight clinical trials in Jackson, MS
6 studies for Overweight are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Jackson Heart Clinic, Jackson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 3
- AURORA-1 Clinical Site, Jackson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Jackson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
RecruitingPhase 3Healthy volunteers welcome
- ACCOMPLISH-2 Research Site, Ridgeland · 9 mi away
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Sky Integrative Medical Center, Ridgeland · 9 mi away
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
RecruitingPhase 3
- ACCOMPLISH-1 Research Site, Ridgeland · 9 mi away
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL28 studies
- Orlando, FL27 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Atlanta, GA20 studies
- Dallas, TX20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in Jackson
- Obesity8 studies
- Steatotic Liver Disease5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Prostate Cancer5 studies
- Breast Cancer5 studies
- Sickle Cell Disease5 studies
- Heart Failure5 studies
- Type 2 Diabetes5 studies
- Burkitt Lymphoma4 studies
- Acute Myeloid Leukemia4 studies
- Attention Deficit Hyperactivity Disorder4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.